Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0063 | 1 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |